drugset / Trial / NCT06385158

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population

NCT06385158 ↗

Phase 1 Completed 110 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Phase I clinical study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral dose escalation of GS1-144 tablets and the effects of food on the pharmacokinetics of GS1-144 in a Chinese population

Timeline

Start
2024-01-03
Primary completion
2024-01-06
Completion
2024-11-05

Drugs

EvaluationDrugModalityDoseRoute
Subject GS1-144 Unknown — Oral

Indications

No indication recorded.